Cadonilimab in the treatment of advanced metastatic soft tissue clear cell sarcoma achieved complete remission: a case report
-
By
-
Yanzhe Wang
-
Xiangqin Wang
-
Mi Meng
-
Yuju Bai
-
Hu Ma
-
Sisi He
-
June 5, 2026
-
Clinical Scorecard: Complete Remission Achieved with Cadonilimab in a Case of Advanced Metastatic Clear Cell Sarcoma: A Case Study
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Patients with advanced metastatic clear cell sarcoma (CCS) should be defined based on the source. |
| Care Setting | |
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
- Initial treatment includes surgery, followed by chemotherapy and immunotherapy.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
A 33-year-old male with advanced metastatic clear cell sarcoma.
Cadonilimab was administered after multiple lines of therapy failed.
Clinical Best Practices
Related Resources & Content
